Timothyp Noyes News Today

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) shot up 3.6% during mid-day trading on Thursday . The company traded as high as $24.05 and last traded at $23.86. 59,742 shares traded hands during trading, a decline of 62% from the average session volume of 159,164 shares. The stock had previously closed at $23.02. Wall […]

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) CEO Timothy P. Noyes sold 10,000 shares of the stock in a transaction on Thursday, May 16th. The stock was sold at an average price of $21.58, for a total value of $215,800.00. The sale was disclosed in a document filed with the SEC, which can be […]

Wedbush reaffirmed their outperform rating on shares of Aerovate Therapeutics (NASDAQ:AVTE – Free Report) in a research note released on Tuesday, Benzinga reports. They currently have a $41.00 price target on the stock. Wedbush also issued estimates for Aerovate Therapeutics’ Q2 2024 earnings at ($0.71) EPS, Q3 2024 earnings at ($0.66) EPS, Q4 2024 earnings […]

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) CEO Timothy P. Noyes sold 11,357 shares of the company’s stock in a transaction dated Wednesday, May 1st. The stock was sold at an average price of $20.34, for a total transaction of $231,001.38. The sale was disclosed in a filing with the Securities & Exchange Commission, […]

Shares of Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) saw an uptick in trading volume on Wednesday . 197,194 shares changed hands during trading, an increase of 52% from the previous session’s volume of 129,738 shares.The stock last traded at $22.91 and had previously closed at $23.22. Analyst Ratings Changes Several analysts have recently […]

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report)’s share price traded down 5.4% during trading on Friday following insider selling activity. The stock traded as low as $25.41 and last traded at $25.44. 26,002 shares were traded during mid-day trading, a decline of 80% from the average session volume of 126,858 shares. The stock had […]

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) CEO Timothy P. Noyes sold 10,000 shares of Aerovate Therapeutics stock in a transaction that occurred on Monday, April 1st. The shares were sold at an average price of $30.00, for a total value of $300,000.00. The transaction was disclosed in a filing with the SEC, which […]

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Free Report) – Stock analysts at Wedbush dropped their Q3 2023 earnings per share (EPS) estimates for shares of Aerovate Therapeutics in a research report issued to clients and investors on Tuesday, August 15th. Wedbush analyst A. Argyrides now expects that the company will post earnings of ($0.65) per share […]

Aerovate Therapeutics (NASDAQ:AVTE – Get Free Report)‘s stock had its “outperform” rating restated by equities research analysts at Wedbush in a research note issued to investors on Tuesday, RTT News reports. They presently have a $48.00 price objective on the stock, down from their prior price objective of $50.00. Wedbush’s price target suggests a potential […]

Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) CEO Timothy P. Noyes sold 5,478 shares of the stock in a transaction that occurred on Friday, July 28th. The stock was sold at an average price of $18.00, for a total transaction of $98,604.00. The transaction was disclosed in a legal filing with the Securities & […]